Medicare Program; Meeting of the Practicing Physicians Advisory Council, March 6, 2006, 4591-4592 [E6-702]
Download as PDF
Federal Register / Vol. 71, No. 18 / Friday, January 27, 2006 / Notices
rmajette on PROD1PC67 with NOTICES
no lower than the current indirect PE
RVUs.
In comments on the CY 2006 PFS
proposed rule, commenters indicated
that they did not understand the
mechanics of our proposals and that
there was not enough information for
specialties to analyze them. Many
commenters requested a 1-year delay in
implementation of our proposals to
allow time for CMS to provide further
information and to give other specialties
an additional opportunity to submit
their own supplementary survey.
After reviewing the CY 2006 PFS
proposed rule comments, we
determined that the proposal for
revising the indirect PE was confusing
to the public because the published PE
values and impacts were incorrect.
Therefore, in the CY 2006 PFS final rule
(70 FR 70116), we withdrew the
proposed PE revision for 2006 and used
the 2005 PE RVUs for most services. The
only exceptions were to price the codes
that were new in 2006 and, as required
by the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) (Pub. L 108–173), to use
the new urology PE data in the
calculation of the drug administration
codes used by their specialty.
As we indicated when we issued the
CY 2006 PFS final rule (70 FR 70116),
we intend to work with the medical
community to ensure that any future
proposals to change the PE methodology
are understandable and informed by
input from the medical community. As
the initial step in this process, we are
holding this Town Hall meeting to
provide this opportunity.
II. Meeting Format
This meeting will begin with an
overview of the objectives of the
meeting along with an introduction of
the topics to be discussed during the
meeting which include:
• Clarifying our efforts to revise the
PE methodology in the CY 2006 PFS
proposed rule which include:
+ The change from a ‘‘top-down’’
methodology for calculating direct PE to
a ‘‘bottom-up’’ approach utilizing the
direct cost inputs;
+ The use of the accepted
supplementary PE surveys from the
seven specialties in the calculation of
indirect PE;
+ The intended method of obtaining
the indirect PE values; and
+ The elimination of the
nonphysician workpool and the related
impacts.
• A question and answer session that
offers the meeting attendees an
opportunity to clarify further the topics
discussed.
VerDate Aug<31>2005
15:17 Jan 26, 2006
Jkt 208001
• Soliciting input from individual
attendees on each facet of our
methodology: direct PE, indirect PE,
supplementary surveys, and
nonphysician workpool. The comments
provided during this meeting will assist
us in the preparation of the physician
fee schedule proposed rule for CY 2007.
To provide a basis of understanding
before the meeting we will be posting
information concerning the PE
methodology on our Web site at https://
www.cms.hhs.gov/PhysicianFeeSched/.
This information will include current
PE values, examples for deriving PE
values using the bottom-up
methodology, and projected impacts of
these revisions. We encourage
individuals to familiarize themselves
with this material before the meeting.
Copies of this information will be
available on the day of the meeting.
Authority
(Catalog of Federal Domestic Assistance
Program No. 93.774, Medicare—
Supplementary Medical Insurance Program).
Dated: January 19, 2006.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 06–747 Filed 1–26–06; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare and Medicaid
Services
[CMS–1318–N]
Medicare Program; Meeting of the
Practicing Physicians Advisory
Council, March 6, 2006
Centers for Medicare and
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces a
quarterly meeting of the Practicing
Physicians Advisory Council (the
Council). The Council will meet to
discuss certain proposed changes in
regulations and carrier manual
instructions related to physicians’
services, as identified by the Secretary
of Health and Human Services (the
Secretary). This meeting is open to the
public.
DATES: The Council meeting is
scheduled for Monday, March 6, 2006,
from 8 a.m. until 5 p.m. e.s.t.
ADDRESS: The meeting will be held in
Room 705A 7th floor, in the Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
4591
Persons wishing
to attend this meeting must register by
contacting Kelly Buchanan, the
Designated Federal Official (DFO) by email at PPAC@cms.hhs.gov or by
telephone at (410) 786–6132, at least 72
hours in advance of the meeting. This
meeting will be held in a Federal
Government Building, Hubert H.
Humphrey Building, and persons
attending the meeting will be required
to show a photographic identification,
preferably a valid driver’s license, and
will be listed on an approved security
list before persons are permitted
entrance. Persons not registered in
advance will not be permitted into the
Hubert H. Humphrey Building and will
not be permitted to attend the Council
meeting.
FOR FURTHER INFORMATION CONTACT:
Kelly Buchanan, (410) 786–6132, or email PPAC@cms.hhs.gov. News media
representatives must contact the CMS
Press Office, (202) 690–6145. Please
refer to the CMS Advisory Committees’
Information Line (1–877–449–5659 toll
free), (410) 786–9379 local) or the
Internet at https://www.cms.hhs.gov/
faca/ppac/default.asp for additional
information and updates on committee
activities.
SUPPLEMENTARY INFORMATION: In
accordance with section 10(a) of the
Federal Advisory Committee Act, this
notice announces the quarterly meeting
of the Practicing Physicians Advisory
Council (the Council). The Secretary is
mandated by section 1868(a)(1) of the
Social Security Act (the Act) to appoint
a Practicing Physicians Advisory
Council based on nominations
submitted by medical organizations
representing physicians. The Council
meets quarterly to discuss certain
proposed changes in regulations and
carrier manual instructions related to
physicians’ services, as identified by the
Secretary. To the extent feasible and
consistent with statutory deadlines, the
Council’s consultation must occur
before Federal Register publication of
the proposed changes. The Council
submits an annual report on its
recommendations to the Secretary and
the Administrator of the Centers for
Medicare and Medicaid Services (CMS)
not later than December 31 of each year.
The Council consists of 15 physicians,
including the Chair. Members of the
Council include both participating and
nonparticipating physicians, and
physicians practicing in rural and
underserved urban areas. At least 11
members of the Council must be
physicians as described in section
1861(r)(1) of the Act; that is, Statelicensed doctors of medicine or
MEETING REGISTRATION:
E:\FR\FM\27JAN1.SGM
27JAN1
rmajette on PROD1PC67 with NOTICES
4592
Federal Register / Vol. 71, No. 18 / Friday, January 27, 2006 / Notices
osteopathy. The remaining 4 members
may include dentists, podiatrists,
optometrists and chiropractors.
Members serve for overlapping 4-year
terms; terms of more than 2 years are
contingent upon the renewal of the
Council by appropriate action prior to
its termination.
Section 1868(a)(2) of the Act provides
that the Council meet quarterly to
discuss certain proposed changes in
regulations and manual issuances that
relate to physicians’ services, identified
by the Secretary. Council members are
expected to participate in all meetings.
Section 1868(a)(3) of the Act provides
for payment of expenses and a per diem
allowance for Council members at a rate
equal to payment provided members of
other advisory committees. In addition
to making these payments, the
Department of Health and Human
Services and CMS provide management
and support services to the Council. The
Secretary will appoint new members to
the Council from among those
candidates determined to have the
expertise required to meet specific
agency needs in a manner to ensure
appropriate balance of the Council’s
membership.
The Council held its first meeting on
May 11, 1992. The current members are:
Ronald Castellanos, M.D., Chairperson;
Jose Azocar, M.D.; M. Leroy Sprang,
M.D.; Rebecca Gaughan, M.D.; Peter
Grimm, D.O.; Carlos R. Hamilton, M.D.;
Dennis K. Iglar, M.D.; Joe Johnson, D.C.;
Christopher Leggett, M.D.; Barbara
McAneny, M.D.; Geraldine O’Shea,
D.O.; Laura B. Powers, M.D.; Gregory J.
Przybylski, M.D.; Anthony Senagore,
M.D.; and Robert L. Urata, M.D.
The meeting will commence with the
Council’s Executive Director providing a
status report and the CMS responses to
the recommendations made by the
Council at the December 5, 2005
meeting as well as prior meeting
recommendations. Additionally, an
update will be provided on the
Physician Regulatory Issues Team. In
accordance with the Council charter, we
are requesting assistance with the
following agenda topics:
• Moving Towards Pay for
Performance.
• Update on Implementation of Part D
Drug Program.
• Medicare Contractor Reform.
• Medicare Health Support.
For additional information and
clarification on these topics, contact the
DFO as provided in the FOR FURTHER
INFORMATION CONTACT section of this
notice. Individual physicians or medical
organizations that represent physicians
wishing to make a 5-minute oral
presentation on agenda issues must
VerDate Aug<31>2005
15:17 Jan 26, 2006
Jkt 208001
contact the DFO by 12 noon, e.s.t.,
February 17, 2006, to be scheduled.
Testimony is limited to agenda topics
only. The number of oral presentations
may be limited by the time available. A
written copy of the presenter’s oral
remarks must be submitted to Kelly
Buchanan, DFO, no later than 12 noon,
e.s.t., February 17, 2006, for distribution
to Council members for review prior to
the meeting. Physicians and medical
organizations not scheduled to speak
may also submit written comments to
the DFO for distribution no later than
noon, e.s.t., February 17, 2006. The
meeting is open to the public, but
attendance is limited to the space
available.
Special Accommodations: Individuals
requiring sign language interpretation or
other special accommodation must
contact the DFO by e-mail at
PPAC@cms.hhs.gov or by telephone at
(410) 786–6132 at least 10 days before
the meeting.
Authority: Section 1868 of the Social
Security Act (42 U.S.C. 1395ee) and section
10(a) of Pub. L. 92–463 (5 U.S.C. App. 2,
section 10(a)).
Dated: January 5, 2006.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. E6–702 Filed 1–26–06; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004E–0314]
Determination of Regulatory Review
Period for Purposes of Patent
Extension; SPIRIVA HANDIHALER
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) has determined
the regulatory review period for
SPIRIVA HANDIHALER and is
publishing this notice of that
determination as required by law. FDA
has made the determination because of
the submission of an application to the
Director of Patents and Trademarks,
Department of Commerce, for the
extension of a patent that claims that
human drug product.
ADDRESSES: Submit written comments
and petitions to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
electronic comments to https://
www.fda.gov/dockets/ecomments.
FOR FURTHER INFORMATION CONTACT:
Claudia V. Grillo, Office of Regulatory
Policy (HFD–013), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 240–453–6681.
SUPPLEMENTARY INFORMATION: The Drug
Price Competition and Patent Term
Restoration Act of 1984 (Public Law 98–
417) and the Generic Animal Drug and
Patent Term Restoration Act (Public
Law 100–670) generally provide that a
patent may be extended for a period of
up to 5 years so long as the patented
item (human drug product, animal drug
product, medical device, food additive,
or color additive) was subject to
regulatory review by FDA before the
item was marketed. Under these acts, a
product’s regulatory review period
forms the basis for determining the
amount of extension an applicant may
receive.
A regulatory review period consists of
two periods of time: a testing phase and
an approval phase. For human drug
products, the testing phase begins when
the exemption to permit the clinical
investigations of the drug becomes
effective and runs until the approval
phase begins. The approval phase starts
with the initial submission of an
application to market the human drug
product and continues until FDA grants
permission to market the drug product.
Although only a portion of a regulatory
review period may count toward the
actual amount of extension that the
Director of Patents and Trademarks may
award (for example, half the testing
phase must be subtracted, as well as any
time that may have occurred before the
patent was issued), FDA’s determination
of the length of a regulatory review
period for a human drug product will
include all of the testing phase and
approval phase as specified in 35 U.S.C.
156(g)(1)(B).
FDA recently approved for marketing
the human drug product SPIRIVA
HANDIHALER (tiotropium bromide
monohydrate). SPIRIVA HANDIHALER
is indicated for the long-term, once
daily, maintenance treatment of
bronchospasm associated with chronic
obstructive pulmonary disease (COPD),
including chronic bronchitis and
emphysema. Subsequent to this
approval, the Patent and Trademark
Office received a patent term restoration
application for SPIRIVA HANDIHALER
(U.S. Patent No. 5,610,163) from
Boehringer Ingelheim Corporation, and
the Patent and Trademark Office
requested FDA’s assistance in
determining this patent’s eligibility for
patent term restoration. In a letter dated
E:\FR\FM\27JAN1.SGM
27JAN1
Agencies
[Federal Register Volume 71, Number 18 (Friday, January 27, 2006)]
[Notices]
[Pages 4591-4592]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-702]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare and Medicaid Services
[CMS-1318-N]
Medicare Program; Meeting of the Practicing Physicians Advisory
Council, March 6, 2006
AGENCY: Centers for Medicare and Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces a quarterly meeting of the Practicing
Physicians Advisory Council (the Council). The Council will meet to
discuss certain proposed changes in regulations and carrier manual
instructions related to physicians' services, as identified by the
Secretary of Health and Human Services (the Secretary). This meeting is
open to the public.
DATES: The Council meeting is scheduled for Monday, March 6, 2006, from
8 a.m. until 5 p.m. e.s.t.
ADDRESS: The meeting will be held in Room 705A 7th floor, in the Hubert
H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC
20201.
MEETING REGISTRATION: Persons wishing to attend this meeting must
register by contacting Kelly Buchanan, the Designated Federal Official
(DFO) by e-mail at PPAC@cms.hhs.gov or by telephone at (410) 786-6132,
at least 72 hours in advance of the meeting. This meeting will be held
in a Federal Government Building, Hubert H. Humphrey Building, and
persons attending the meeting will be required to show a photographic
identification, preferably a valid driver's license, and will be listed
on an approved security list before persons are permitted entrance.
Persons not registered in advance will not be permitted into the Hubert
H. Humphrey Building and will not be permitted to attend the Council
meeting.
FOR FURTHER INFORMATION CONTACT: Kelly Buchanan, (410) 786-6132, or e-
mail PPAC@cms.hhs.gov. News media representatives must contact the CMS
Press Office, (202) 690-6145. Please refer to the CMS Advisory
Committees' Information Line (1-877-449-5659 toll free), (410) 786-9379
local) or the Internet at https://www.cms.hhs.gov/faca/ppac/default.asp
for additional information and updates on committee activities.
SUPPLEMENTARY INFORMATION: In accordance with section 10(a) of the
Federal Advisory Committee Act, this notice announces the quarterly
meeting of the Practicing Physicians Advisory Council (the Council).
The Secretary is mandated by section 1868(a)(1) of the Social Security
Act (the Act) to appoint a Practicing Physicians Advisory Council based
on nominations submitted by medical organizations representing
physicians. The Council meets quarterly to discuss certain proposed
changes in regulations and carrier manual instructions related to
physicians' services, as identified by the Secretary. To the extent
feasible and consistent with statutory deadlines, the Council's
consultation must occur before Federal Register publication of the
proposed changes. The Council submits an annual report on its
recommendations to the Secretary and the Administrator of the Centers
for Medicare and Medicaid Services (CMS) not later than December 31 of
each year.
The Council consists of 15 physicians, including the Chair. Members
of the Council include both participating and nonparticipating
physicians, and physicians practicing in rural and underserved urban
areas. At least 11 members of the Council must be physicians as
described in section 1861(r)(1) of the Act; that is, State-licensed
doctors of medicine or
[[Page 4592]]
osteopathy. The remaining 4 members may include dentists, podiatrists,
optometrists and chiropractors. Members serve for overlapping 4-year
terms; terms of more than 2 years are contingent upon the renewal of
the Council by appropriate action prior to its termination.
Section 1868(a)(2) of the Act provides that the Council meet
quarterly to discuss certain proposed changes in regulations and manual
issuances that relate to physicians' services, identified by the
Secretary. Council members are expected to participate in all meetings.
Section 1868(a)(3) of the Act provides for payment of expenses and a
per diem allowance for Council members at a rate equal to payment
provided members of other advisory committees. In addition to making
these payments, the Department of Health and Human Services and CMS
provide management and support services to the Council. The Secretary
will appoint new members to the Council from among those candidates
determined to have the expertise required to meet specific agency needs
in a manner to ensure appropriate balance of the Council's membership.
The Council held its first meeting on May 11, 1992. The current
members are: Ronald Castellanos, M.D., Chairperson; Jose Azocar, M.D.;
M. Leroy Sprang, M.D.; Rebecca Gaughan, M.D.; Peter Grimm, D.O.; Carlos
R. Hamilton, M.D.; Dennis K. Iglar, M.D.; Joe Johnson, D.C.;
Christopher Leggett, M.D.; Barbara McAneny, M.D.; Geraldine O'Shea,
D.O.; Laura B. Powers, M.D.; Gregory J. Przybylski, M.D.; Anthony
Senagore, M.D.; and Robert L. Urata, M.D.
The meeting will commence with the Council's Executive Director
providing a status report and the CMS responses to the recommendations
made by the Council at the December 5, 2005 meeting as well as prior
meeting recommendations. Additionally, an update will be provided on
the Physician Regulatory Issues Team. In accordance with the Council
charter, we are requesting assistance with the following agenda topics:
Moving Towards Pay for Performance.
Update on Implementation of Part D Drug Program.
Medicare Contractor Reform.
Medicare Health Support.
For additional information and clarification on these topics,
contact the DFO as provided in the For Further Information Contact
section of this notice. Individual physicians or medical organizations
that represent physicians wishing to make a 5-minute oral presentation
on agenda issues must contact the DFO by 12 noon, e.s.t., February 17,
2006, to be scheduled. Testimony is limited to agenda topics only. The
number of oral presentations may be limited by the time available. A
written copy of the presenter's oral remarks must be submitted to Kelly
Buchanan, DFO, no later than 12 noon, e.s.t., February 17, 2006, for
distribution to Council members for review prior to the meeting.
Physicians and medical organizations not scheduled to speak may also
submit written comments to the DFO for distribution no later than noon,
e.s.t., February 17, 2006. The meeting is open to the public, but
attendance is limited to the space available.
Special Accommodations: Individuals requiring sign language
interpretation or other special accommodation must contact the DFO by
e-mail at PPAC@cms.hhs.gov or by telephone at (410) 786-6132 at least
10 days before the meeting.
Authority: Section 1868 of the Social Security Act (42 U.S.C.
1395ee) and section 10(a) of Pub. L. 92-463 (5 U.S.C. App. 2,
section 10(a)).
Dated: January 5, 2006.
Mark B. McClellan,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. E6-702 Filed 1-26-06; 8:45 am]
BILLING CODE 4120-01-P